Microwave Ablation (MWA)

PROCEDURE6 trials

Sponsors

University of Wisconsin, Madison, University of Michigan Rogel Cancer Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Francesco De Cobelli

Conditions

AscitesCarcinoma, HepatocellularCarcinoma, Renal CellCirrhosis, LiverHepatocellular CarcinomaHepatocellular Carcinoma (HCC)Kidney CancerLiver Cancer

Phase 1

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

TerminatedNCT02782715

University of Wisconsin, MadisonCarcinoma, Renal Cell

Start: 2018-06-28End: 2023-01-10Updated: 2024-03-20

Phase 2

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

CompletedNCT03753659

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestHepatocellular Carcinoma (HCC)

Start: 2019-05-09End: 2024-04-30Updated: 2026-03-23

Unknown Phase

Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma

WithdrawnNCT03168152

University of Michigan Rogel Cancer CenterCarcinoma, Hepatocellular

Start: 2017-05-11End: 2022-04-01Updated: 2018-06-25

Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityMicrowave Ablation, Recurrent Hepatocellular Carcinoma, Stereotactic Body Radiotherapy

Start: 2018-06-30End: 2021-05-31Target: 110Updated: 2018-08-01

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

RecruitingNCT03981497

Francesco De CobelliKidney Cancer, Liver Cancer, Liver Metastasis Colon Cancer +1

Start: 2018-02-28End: 2030-12-31Target: 500Updated: 2024-04-12

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

Sun Yat-sen UniversityAscites, Cirrhosis, Liver, Hepatocellular Carcinoma +2

Start: 2021-02-01End: 2023-06-30Target: 30Updated: 2020-12-19

Related Papers

IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC)—The IKF-IMMULAB trial.

Journal of Clinical Oncology2025-01-27

Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and <sup>99m</sup>Tc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization <sup>90</sup>Y PET/CT.

2024-12-201 citations

IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC).

Journal of Clinical Oncology2023-01-244 citations

The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC).

Journal of Clinical Oncology2021-05-203 citations